Skinbiotherapeutics Plc

Skinbiotherapeutics (SBTX)

Company name:Skinbiotherapeutics Plc
Company Description:SkinBioTherapeutics is a life science company focused on skin health.
EPIC:SBTXTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BF33H870
Market Segment:ASQ1Share Type:DE
WWW Address:http://www.skinbiotherapeutics.com/Description:ORD 1P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 13.50 images.advfn.com/imagesnew/2/gb/down -0.75 [-5.26] 13.00 14.00 14.25 14.25 13.50 125,942
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 16.03 118.71 -0.00 -0.71 - - - 25.75 - 12.25

Skinbiotherapeutics Key Figures

(at previous day's close)
Market Cap.16.03m
Shares In Issue118.71m
Prev. Close14.25
PE Ratio- 
Dividend Yield-%
EPS - basic-0.71p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-0.56p
Return On Equity (ROE)-24.54%
Operating Margin-%
PEG Factor- 
EPS Growth Rate36.04%
Dividends PS Growth Rate-%
Net Debt-2.97m
Gross Gearing5.73%
Quick Assets3.36m
Net Working Capital3.15m
Intangibles / Fixed Assets100.00%
Turnover PS-p
Pre-Tax Profit PS-0.79p
Retained Profit PS-0.71p
Cash PS2.68p
Net Cash PS2.50p
Net Tangible Asset Value PS *2.66p
Net Asset Value PS2.90p
Spread1.00 (7.14%) 

Skinbiotherapeutics Balance Sheet

SBTX:Liabilities+EQSBTX:Assets

Share Price Performance

Sample Period HighLow
1 week15.0013.50
4 weeks19.0013.50
12 weeks19.5013.50
1 year25.7512.25

Share Price Chart (5 years)

Skinbiotherapeutics Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week14.50-1.00-6.9013.500.0414.44
4 weeks18.50-5.00-27.0313.500.2716.51
12 weeks14.50-1.00-6.9013.500.3617.19
26 weeks23.00-9.50-41.3012.250.2417.19
1 year14.25-0.75-5.2612.250.2418.04
3 years13.250.251.897.350.3315.80
5 years13.250.251.897.350.3315.80

Skinbiotherapeutics Key Management Ratios

Skinbiotherapeutics Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 4.02 
Tobin's Q Ratio (excl. intangibles)4.29 
Dividend Yield-%
Market-to-Book Ratio4.66 
Price-to-Pre-Tax Profit PS-17.02 
Price-to-Retained Profit PS-18.98 
Price-to-Cash Flow PS-24.00 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS5.08 
Price-to-Cash PS5.03 
Net Working Capital PS2.66 
Price Pct to Working Capital PS5.08%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Skinbiotherapeutics Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing-81.46%
Net Gearing (excl. Intangibles)-88.43%
Gross Gearing5.73%
Gross Gearing (excl. Intangibles)6.22%
Gearing Under 1 Year5.73%
Gearing Under 1 Year (excl. Intgbl)6.22%
Assets/Equity1.06 
Cash/Equity92.50 
(Liquidity Ratios)
Net Working Capital to Total Assets86.39%
Current Ratio16.07 
Quick Ratio (Acid Test)16.07 
Liquidity Ratio15.21 
Cash & Equiv/Current Assets94.66%
(Solvency Ratios)
Enterprise Value12.84m
CFO/Sales- 
CFO/Attributable Profit- 
CFO/Assets-0.18 
CFO/Debt-3.19 
Total Debt/Equity Market Value0.01 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-0.22 
Total Debt0.21m
Total Debt/Net Current Assets0.07%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs- 
Beta (60-Mnth)Beta (36-Mnth)
-0.0013-0.0013

Skinbiotherapeutics Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-27.36%
Return On Assets (ROA)-21.16%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-24.54%
Return On Investment (ROI)-22.06%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debtors-to-Sales-%
Debt Collection Period-Days

Skinbiotherapeutics Dividends

Sorry No Data Available

Skinbiotherapeutics Fundamentals

 30 Jun 2017 (GBP)30 Jun 2018 (GBP)
turnover----m
pre tax profit-0.69--0.94-m
attributable profit-0.65--0.84-m
retained profit-0.65--0.84-m
eps - basic (p)-1.11 -0.71 
eps - diluted (p)-1.11 -0.71 
dividends per share- - 

Skinbiotherapeutics Balance Sheet

 30 Jun 2017 (GBP)30 Jun 2018 (GBP)
SBTX:Liabilities+EQSBTX:AssetsSBTX:Liabilities+EQSBTX:Assets
 30 Jun 2017 (GBP)30 Jun 2018 (GBP)
ASSETS
fixed assets fixed assets--%--%m
intangibles intangibles0.224.97%0.297.88%m
fixed investments fixed investments--%--%m
current assets - other current assets - other0.040.99%--%m
stocks stocks--%--%m
debtors debtors0.153.49%0.184.92%m
cash & securities cash & securities3.9290.55%3.1887.20%m
TOTAL4.33100%3.65100%m
LIABILITIES
creditors - short creditors - short0.122.74%0.215.73%m
creditors - long creditors - long--%--%m
creditors - other creditors - other--%--%m
subordinated loans subordinated loans--%--%m
insurance funds insurance funds--%--%m
TOTAL0.122.74%0.215.73%m
EQUITY
ord cap, reserves ord cap, reserves4.2197.26%3.4494.27%m
prefs, minorities prefs, minorities--%--%m
TOTAL4.2197.26%3.4494.27%m
OTHER
NAV Basic- - 
NAV Diluted- - 

Skinbiotherapeutics Cash Flow Statement

30 Jun 2017 (GBP)30 Jun 2018 (GBP)
Operating CF-0.61-0.67m
Pre-Financing CF-0.69-0.74m
Retained CF3.67-0.74m

Skinbiotherapeutics Brokers

Broker infomation is not available for this class of stock.
Your Recent History
LSE
SBTX
Skinbiothe..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191211 01:31:32